Company · CIK 1875091
NeuroSense Therapeutics Ltd.
| CIK | 1875091 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | L3 |
| Business address | Israel |
| Listed | NRSN (Nasdaq), NRSNW (Nasdaq) |
| First annual or quarterly report | 2022-04-14 |
Offerings
9 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-293060 | 2026-01-29 | 2026-07-31 | 2 | |
| 333-291122 | 2025-10-28 | 2025-11-25 | 2 | |
| 333-273375 | 2023-07-21 | 2025-08-18 | 8 | |
| 333-283338 | 2024-11-19 | 2025-08-18 | 4 | |
| 333-269306 | 2023-01-19 | 2025-08-08 | 9 | |
| 333-284051 | 2024-12-26 | 2025-01-16 | 2 | |
| 333-283656 | 2024-12-06 | 2024-12-12 | 2 | |
| 333-279324 | 2024-05-10 | 2024-05-22 | 3 | |
| 333-260338 | 2021-10-18 | 2024-04-08 | 9 |
Filings
42| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-07-31 | EFFECTDeclared effective | 333-293060 | 9999999995-26-002505 |
| 2026-01-29 | F-3Shelf registered | 333-293060 | 0001213900-26-009643 |
| 2025-11-25 | EFFECTDeclared effective | 333-291122 | 9999999995-25-003390 |
| 2025-10-28 | F-3Shelf registered | 333-291122 | 0001213900-25-103109 |
| 2025-08-18 | EFFECTDeclared effective | 333-283338 | 9999999995-25-002658 |
| 2025-08-18 | EFFECTDeclared effective | 333-273375 | 9999999995-25-002655 |
| 2025-08-08 | 424B5Shelf takedown | 333-269306 | 0001213900-25-073671 |
| 2025-04-16 | EFFECTDeclared effective | 333-283338 | 9999999995-25-001128 |
| 2025-04-16 | EFFECTDeclared effective | 333-273375 | 9999999995-25-001126 |
| 2025-02-21 | 424B5Shelf takedown | 333-269306 | 0001213900-25-016104 |
| 2025-01-16 | EFFECTDeclared effective | 333-284051 | 9999999995-25-000133 |
| 2024-12-26 | F-3Shelf registered | 333-284051 | 0001213900-24-112695 |
| 2024-12-12 | EFFECTDeclared effective | 333-283656 | 9999999995-24-003768 |
| 2024-12-06 | F-3Shelf registered | 333-283656 | 0001213900-24-106506 |
| 2024-11-22 | EFFECTDeclared effective | 333-283338 | 9999999995-24-003567 |
| 2024-11-19 | F-1Registration filed | 333-283338 | 0001213900-24-100165 |
| 2024-10-04 | EFFECTDeclared effective | 333-273375 | 9999999995-24-003091 |
| 2024-08-16 | 424B5Shelf takedown | 333-269306 | 0001213900-24-070237 |
| 2024-05-22 | EFFECTDeclared effective | 333-279324 | 9999999995-24-001623 |
| 2024-05-20 | F-1/AAmendment | 333-279324 | 0001213900-24-045192 |
| 2024-05-10 | F-1Registration filed | 333-279324 | 0001213900-24-041733 |
| 2024-04-12 | 424B5Shelf takedown | 333-269306 | 0001213900-24-032578 |
| 2024-04-08 | EFFECTDeclared effective | 333-273375 | 9999999995-24-000884 |
| 2024-04-08 | EFFECTDeclared effective | 333-260338 | 9999999995-24-000881 |
| 2023-12-04 | EFFECTDeclared effective | 333-260338 | 9999999995-23-003522 |
| 2023-09-05 | EFFECTDeclared effective | 333-273375 | 9999999995-23-002571 |
| 2023-08-31 | F-1/AAmendment | 333-273375 | 0001213900-23-072836 |
| 2023-08-14 | F-1/AAmendment | 333-273375 | 0001213900-23-067071 |
| 2023-07-21 | F-1Registration filed | 333-273375 | 0001213900-23-058862 |
| 2023-06-23 | 424B5Shelf takedown | 333-269306 | 0001213900-23-051352 |
| 2023-06-22 | 424B5Shelf takedown | 333-269306 | 0001213900-23-050708 |
| 2023-04-14 | 424B5Shelf takedown | 333-269306 | 0001213900-23-029920 |
| 2023-01-30 | EFFECTDeclared effective | 333-269306 | 9999999995-23-000224 |
| 2023-01-19 | F-3Shelf registered | 333-269306 | 0001213900-23-003838 |
| 2021-12-10 | 424B4Final prospectus | 333-260338 | 0001213900-21-064532 |
| 2021-12-08 | EFFECTDeclared effective | 333-260338 | 9999999995-21-004606 |
| 2021-12-06 | F-1/AAmendment | 333-260338 | 0001213900-21-063522 |
| 2021-11-19 | F-1/AAmendment | 333-260338 | 0001213900-21-060769 |
| 2021-11-10 | F-1/AAmendment | 333-260338 | 0001213900-21-058163 |
| 2021-11-01 | F-1/AAmendment | 333-260338 | 0001213900-21-055773 |
| 2021-10-18 | F-1Registration filed | 333-260338 | 0001213900-21-053322 |
| 2021-08-10 | DRSDraft made public | 377-05333 | 0001213900-21-041133 |